2025³â 08¿ù 07ÀÏ ¸ñ¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92547°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



ÅÂÇ×È£, MBC ¡®¸Þ¸® ųÁî ÇÇÇᯠÃ⿬

ºÎÇü»ç·Î º¯½Å, Á¶·Â»ç¸Á »ç°Ç ÃßÀû
¹è¿ì ÅÂÇ×È£°¡ Áö³­ 1ÀÏ Ã¹ ¹æ¼ÛµÈ MBC ±ÝÅäµå¶ó¸¶ ‘¸Þ¸® ųÁî ÇÇÇÃ’(±âȹ ±Ç¼ºÃ¢ / ¿¬Ãâ ¹ÚÁØ¿ì / ±Øº» À̼ö¾Æ / Á¦ÀÛ ¹Ì½ºÅͷθǽº, ¹«ºùÇÈÃĽºÄÄÆÛ´Ï, ½ºÆ©µð¿À ¾ÈÀÚÀÏ·»)À» ÅëÇØ ½ÃûÀÚµé°ú ¸¸³µ´Ù.   ‘¸Þ¸® ųÁî ÇÇÇÃ’Àº Ä¡·á°¡ ºÒ°¡´ÉÇÑ È¯ÀÚµéÀÇ Á¶·Â »ç¸ÁÀ» µ½´Â ÀÇ»ç¿Í À̸¦ ÃßÀûÇÏ´Â Çü»çÀÇ À̾߱⸦ ±×¸° ¼­½ºÆæ½º µå¶ó¸¶´Ù.   ±Ø Áß ÅÂÇ×È£´Â ±¤¼ö´ëÀå żº(±èÅÂ¿ì ºÐ)°ú ÇÔ²² »ç°ÇÀ» ÂÑ´Â ‘ºÎÇü»ç’·Î ºÐÇØ, Á¶·Â »ç¸Á »ç°ÇÀÇ ½Çü¿¡ ´Ù°¡¼­±â À§ÇØ ÇöÀåÀ» ´©ºñ°í ´Ü¼­¸¦ ...

KGM, Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø°ú ÀÚÀ²ÁÖÇà ±â¼úÇù·Â MOU

ÀÚÀ²ÁÖÇà °ü·Ã À¯·´ ¹ý±Ô ´ëÀÀÀº ¹°·Ð ¾ç»ê ±â¼ú È®º¸ ±â´ë
KG ¸ðºô¸®Æ¼(ÀÌÇÏ KGM)°¡ Áö´ÉÇüÀÚµ¿Â÷ºÎǰÁøÈï¿ø (ÀÌÇÏ ÁøÈï¿ø)°ú ÀÚÀ²ÁÖÇà ±â¼ú °³¹ß MOU¸¦ ü°áÇÏ°í »óÈ£Çù·ÂÇϱâ·Î Çß´Ù. Áö³­ 28ÀÏ(¿ù) ÁøÈï¿ø º»»ç(´ë±¸½Ã ´Þ¼º±º ¼ÒÀç)¿¡¼­ ¿­¸° MOU ü°á½Ä¿¡´Â KGM ±Ç¿ëÀÏ ±â¼ú¿¬±¸¼Ò ¼ÒÀå°ú ÁøÈï¿ø ¼­ÀçÇü ¿øÀåÀ» ºñ·ÔÇÑ °ü°èÀÚµéÀÌ Âü¼®Çß´Ù. ÁøÈï¿øÀº ÀÚÀ²ÁÖÇàÂ÷ µî Â÷¼¼´ë ÀÚµ¿Â÷ ±â¼úÀ» °³¹ßÇÏ´Â °ü·Ã ¾÷ü¿Í ¿¬±¸±â°üÀ» Áö¿øÇϱâ À§ÇØ 2014³â ¼³¸³µÈ ½ÃÇè Àü¹® ±â°üÀ¸·Î, °í¼Ó ÁÖȸ·Î, ¹ü¿ë ½ÃÇè·Î µî ´Ù¾çÇÑ Á¶°Ç¿¡¼­ÀÇ ÀÚµ¿Â÷ ÁÖÇà ½ÃÇè ¹× Ãæ°Ý ³»±¸ ½ÃÇè Àåºñ µîÀÇ ½Ã¼³ ¹× ½ÃÇè Àη ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
´ë¿ø, º£Æ®³² ºñÄÚ·£µå±×·ì°ú ÇÕÀÛ °Ç¼³»ç ¼³¸³ (2019-01-09)
·£¼¶¿þ¾î ÇÇÇØ ±â¾÷ 76% ±ÝÀüÀû ´ë°¡ ÁöºÒ (2022-05-21)
°É±×·ì ÇÇ¿¡½ºÅ¸, ¼º¼÷¹Ì ¹°¾À dz±â´Â È­º¸ °ø°³ (2016-05-21)
°ø°øÁÖÅà µðÀÚÀÎ °ø¸ð´ë»óÁö ¼±Á¤ (2019-06-17)
½ÅÇÑÅõÀÚÁõ±Ç, ¹Ì±¹ ½Ç¸®Äܹ븮¼­ ÇöÁö »ç¹«¼Ò ¿ÀÇ (2022-10-27)
BEF99 MBÇÊÅÍ 12cm ÃʼÒÇü ¡®º£À̺ñµ§Å»¸¶½ºÅ©¡¯ (2020-06-22)
EUBEEF ASIA ¡®³ªÀ̽ºÅõºñÇÁÀ¯¡¯ Ä·ÆäÀÎ (2023-02-10)
KG ¸ðºô¸®Æ¼, 3¿ù ³»¼ö¡¤¼öÃâ ÃÑ 1¸¸3679´ë ÆÇ¸Å (2023-04-04)
½ºÆ¿ÄÉÀ̽º, ¡®Ç÷º½º Çãµé Çãºê¡¯ Ãâ½Ã (2021-01-20)
¼Ûµµ, ¸í¹®ÇбºÀ¸·Î ÃÖÀûÀÇ ±³À°È¯°æ Á¶¼º (2014-04-22)
Áֹεî·ÏÁõ »çÁø ±Ô°ÝÁ¶°Ç ¿ÏÈ­µÈ´Ù (2018-11-08)
¡®6¿ù¹ÎÁÖ»ó¡¯ ÁÖÀΰø ã´Â´Ù (2021-03-14)
¼¼°è ÃÖÃÊ ¸¶ÀÌÅ©·Î SDÄ«µå ±â¹Ý ½º¸¶Æ®Æù Äݵå¿ù·¿ (2019-02-22)
2ºÐ±âºÎÅÍ 2±ÝÀ¶±Ç¿¡µµ DSR ÁöÇ¥ µµÀÔ (2019-04-16)
·Ôµ¥¿ùµå, Á¤º¸º¸È£ °ü¸®Ã¼°è ISMS ÃÖÁ¾ ÀÎÁõ ȹµæ (2017-12-16)
¾Æ¿ôµµ¾î ¶óÀÌÇÁµµ ÇÒ¸®½º¿Í ÇÔ²² (2021-10-12)
¡®2018 ¸®¾ó Å©¸®½º¸¶½º¡¯ ¿ö½Ê Äܼ­Æ® °³ÃÖ (2018-12-22)
ÇÚµåÇã±×, ¡®¸¶¹Ì¼Õ ÆË¾÷½ºÅä¾î¡¯ ¿ÀÇ (2018-12-22)
Faraday Continues Expanding Its Ethernet Solutions for Netwo... (2022-05-12)
Çѱ¹, ¿ìÁÖÆøÇ³ ¹× º°»ý¼º ¿¬±¸ÇÑ´Ù (2012-12-04)
Çö´ëÂ÷±×·ì, ¿¡³ÊÁöÀúÀåÀåÄ¡ ½ÇÁõ»ç¾÷ °³½Ã (2021-01-11)
ÇÑ-¹æ±Û¶óµ¥½Ã ¼ö±³ 40Áֳ⠱â³ä ¹®È­Çà»ç ¼º·á (2013-05-03)
³²À¯Èñ, ½Ì¾î¼Û¶óÀÌÅÍ NYOU·Î »õ Ãâ¹ß (2021-08-11)
¿À¶Ñ±â, ¡®¶ø½ºÅÍ ¶ó¸é¡¯ Ãâ½Ã (2022-03-11)
GS25, ³ÝÇø¯½º¿Í ¼ÕÀâ°í O4O ½Ã³ÊÁö È®´ë ³ª¼­ (2023-05-18)
       [ÀÌÀü][1]....[2719][2720][2721][2722][2723][2724][2725][2726][2727]...[3702][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..